Soybean-Derived Pinitol Improves a Host of Problems in Type 2s

Feb 1, 2005

Pinitol, isolated from soybeans, may be beneficial in reducing cardiovascular risk in type 2s, according to Korean researchers.

In a randomized study, a total of 30 type 2 patients received 600-mg oral doses of soybean-derived pinitol or placebo twice daily for 13 weeks.

Pinitol significantly decreased mean fasting plasma glucose, insulin, fructosamine and A1C. In addition, pinitol decreased total cholesterol, LDL cholesterol, systolic and diastolic blood pressure and increased HDL cholesterol.

European Journal of Clinical Nutrition, November 2004

Click Here To View Or Post Comments

Categories: A1c Test, Insulin, Nutrition Research, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Feb 1, 2005

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.